Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 16, 2018

DrugPatentWatch Database Preview

Exela Pharma Science Company Profile

« Back to Dashboard

What is the competitive landscape for EXELA PHARMA SCIENCE, and what generic and branded alternatives to EXELA PHARMA SCIENCE drugs are available?

EXELA PHARMA SCIENCE has four approved drugs.

Summary for Exela Pharma Science

US Patents:	0
Tradenames:	5
Ingredients:	4
NDAs:	4
Patent Litigation for Exela Pharma Science:	See patent lawsuits for Exela Pharma Science

Drugs and US Patents for Exela Pharma Science

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Exela Pharma Science	IBUPROFEN LYSINE	ibuprofen lysine	INJECTABLE;INTRAVENOUS	202402-001	Mar 30, 2016	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Science	CAFFEINE CITRATE	caffeine citrate	SOLUTION;INTRAVENOUS	077233-001	Sep 21, 2006	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Science	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	022276-003	Apr 7, 2016		RX	No	No		➤ Sign Up				➤ Sign Up
Exela Pharma Science	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	022276-002	Apr 7, 2016		RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS

Citi

Harvard Business School

McKinsey

Accenture

Covington

Dow

US Department of Justice

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.